resistance to semaglutide Mechanism of for management of obesity, NASH, and Why Semaglutide Weight Loss Plateaus
Description
Semaglutide is an FDA-Approved Weight Loss Option In a press announcement released June 4, 2021, the FDA reported that the treatment had improved people suffering from weight-related health issues
The Global Use of Medicines 2023 | IQVIA, (n.d.)
Additionally, Medicare does not cover the GLP-1 medications for weight loss
$717 (billed every 3 months) $339 /mo
Furthermore, the significant weight and fat reduction associated with GLP-1Ra agents may diminish pro-inflammatory cytokine production from adipose tissue such as IL-6
